Call Now: +1 858 800 3101 Email: info@innopep.com
| Overview | |
|---|---|
| Description | VIR-165 is a modified form of virus inhibitory peptide (VIRIP), which corresponds to residues 353 to 372 of C-proximal region of human alpha1-antitrypsin, the most abundant circulating serine protease inhibitor. VIRIP inhibits a wide variety of human immunodeficiency virus type 1 (HIV-1) strains. This modification enhances the antitrypsin ability to inhibit HIV-1infection. | 
| Sequence | {Leu}{Glu}{Ala}{Ile}{Pro}{Cys}{Ser}{Ile}{Pro}{Pro}{Cys}{Phe}{Ala}{Phe}{Asn}{Lys}{Pro}{Phe}{Val}{Phe} | 
| Sequence Shortening | LEAIPCSIPPCFAFNKPFVF | 
| Molecular Formula | C109H158N22O25S2 | 
| Molecular Weight | 2240.7 | 
| Properties | |
| Purity | > 95% | 
| Gmp Flag | 0 | 
| Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. | 
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.